There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:A61P25/28
Jump to navigation
Jump to search
Pages in category "A61P25/28"
The following 18 pages are in this category, out of 18 total.
1
- 18200950. COMPOUNDS FOR TAU PROTEIN DEGRADATION simplified abstract (DANA-FARBER CANCER INSTITUTE, INC.)
- 18215276. METHODS AND COMPOSITIONS FOR IMPROVED COGNITION simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18452059. HUNTINGTIN MIMETIC PROTEIN-LIKE POLYMERS AND USES THEREOF simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
2
- 20240010659. NEW THIADIAZOLOPYRIMIDONE DERIVATIVES simplified abstract (Hoffmann-La Roche Inc.)
- 20240016859. MICROENCAPSULATED AND CHROMOSOME INTEGRATED COMPOSITIONS FOR L-DOPA MICROBIOME THERAPY simplified abstract (Iowa State University Research Foundation, Inc.)
- 20240041900. GLUTAMINE ANTAGONISTS FOR THE TREATMENT OF COGNITIVE DEFICITS AND PSYCHIATRIC DISORDERS simplified abstract (The Johns Hopkins University)
- 20240051975. NOVEL NAMPT ENZYME AGONIST AND PREPARATION AND USE THEREOF simplified abstract (Tsinghua University)
B
- Blockchain patent applications on 22nd Mar 2024
- Blockchain patent applications on April 11th, 2024
- Blockchain patent applications on April 18th, 2024
- Blockchain patent applications on April 25th, 2024
- Blockchain patent applications on February 15th, 2024
- Blockchain patent applications on February 29th, 2024
- Blockchain patent applications on February 8th, 2024
- Blockchain patent applications on January 11th, 2024
- Blockchain patent applications on January 18th, 2024
- Blockchain patent applications on March 21st, 2024
- Blockchain patent applications on March 28th, 2024